The historical rank and industry rank for The Oncology Institute's Price-to-Free-Cash-Flow or its related term are showing as below:
TOI's Price-to-Free-Cash-Flow is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 16.68 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -269.30% per year.
During the past 6 years, The Oncology Institute's highest 3-Year average Free Cash Flow per Share Growth Rate was -269.30% per year. The lowest was -269.30% per year. And the median was -269.30% per year.
The Oncology Institute Price-to-Free-Cash-Flow Historical Data
The historical data trend for The Oncology Institute's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
The Oncology Institute Price-to-Free-Cash-Flow Chart
Competitive Comparison of The Oncology Institute's Price-to-Free-Cash-Flow
For the Medical Care Facilities subindustry, The Oncology Institute's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Oncology Institute's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Oncology Institute's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where The Oncology Institute's Price-to-Free-Cash-Flow falls into.
The Oncology Institute Price-to-Free-Cash-Flow Calculation
The Oncology Institute's Share Price of today is $0.45. The Oncology Institute's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.54.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The Oncology Institute (NAS:TOI) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
The Oncology Institute Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of The Oncology Institute's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
The Oncology Institute (The Oncology Institute) Business Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TOI has been successfully added to your 